Tech Company Financing Transactions
Soft Tissue Regeneration Funding Round
Connecticut Innovations, LaunchCapital and The Vertical Group participated in a $5 million funding round for Soft Tissue Regeneration. The funding round was announced on 1/6/2014.
Transaction Overview
Company Name
Announced On
1/6/2014
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The $5 million financing commitment will permit STR to complete its European Phase I clinical study and continue the FDA regulatory process for the Company's L-C Ligament®, a bioresorbable, implantable scaffold for the repair and regeneration of an injured or torn anterior cruciate ligament ("ACL").
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
142 Temple St. 206
New Haven, CT 06510
USA
New Haven, CT 06510
USA
Phone
Email Address
Overview
Soft Tissue Regeneration has developed and preliminarily tested a potential breakthrough technology for soft tissue regeneration of the anterior cruciate ligament of the knee.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Michael Aronson
Browse more venture capital transactions:
Prev: 1/6/2014: ProspX venture capital transaction
Next: 1/7/2014: Cardiac Dimensions venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. All VC database entries on this site come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs